These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15240708)

  • 1. TLR9 is localized in the endoplasmic reticulum prior to stimulation.
    Leifer CA; Kennedy MN; Mazzoni A; Lee C; Kruhlak MJ; Segal DM
    J Immunol; 2004 Jul; 173(2):1179-83. PubMed ID: 15240708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
    Latz E; Schoenemeyer A; Visintin A; Fitzgerald KA; Monks BG; Knetter CF; Lien E; Nilsen NJ; Espevik T; Golenbock DT
    Nat Immunol; 2004 Feb; 5(2):190-8. PubMed ID: 14716310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 9 mediates CpG-DNA signaling.
    Chuang TH; Lee J; Kline L; Mathison JC; Ulevitch RJ
    J Leukoc Biol; 2002 Mar; 71(3):538-44. PubMed ID: 11867692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
    Roda JM; Parihar R; Carson WE
    J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.
    Ivanov S; Dragoi AM; Wang X; Dallacosta C; Louten J; Musco G; Sitia G; Yap GS; Wan Y; Biron CA; Bianchi ME; Wang H; Chu WM
    Blood; 2007 Sep; 110(6):1970-81. PubMed ID: 17548579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.
    Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H
    Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic Protein Nogo-B (RTN4-B) Interacts with GRAMD4 and Regulates TLR9-Mediated Innate Immune Responses.
    Kimura T; Endo S; Inui M; Saitoh S; Miyake K; Takai T
    J Immunol; 2015 Jun; 194(11):5426-36. PubMed ID: 25917084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of TLR9 activation.
    Latz E; Visintin A; Espevik T; Golenbock DT
    J Endotoxin Res; 2004; 10(6):406-12. PubMed ID: 15588423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z; Guo K; Schluesener HJ
    J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Toll-like receptor9 in diffuse large B-cell lymphoma: further exploring CpG oligodeoxynucleotide in NFκB pathway.
    Huang WT; Weng SW; Huang CC; Lin HC; Tsai PC; Chuang JH
    APMIS; 2012 Nov; 120(11):872-81. PubMed ID: 23009111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Toll-like receptor recognizes bacterial DNA.
    Hemmi H; Takeuchi O; Kawai T; Kaisho T; Sato S; Sanjo H; Matsumoto M; Hoshino K; Wagner H; Takeda K; Akira S
    Nature; 2000 Dec; 408(6813):740-5. PubMed ID: 11130078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 9, CpG DNA and innate immunity.
    Ashkar AA; Rosenthal KL
    Curr Mol Med; 2002 Sep; 2(6):545-56. PubMed ID: 12243247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.
    Tabeta K; Georgel P; Janssen E; Du X; Hoebe K; Crozat K; Mudd S; Shamel L; Sovath S; Goode J; Alexopoulou L; Flavell RA; Beutler B
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3516-21. PubMed ID: 14993594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.
    Ahmad-Nejad P; Häcker H; Rutz M; Bauer S; Vabulas RM; Wagner H
    Eur J Immunol; 2002 Jul; 32(7):1958-68. PubMed ID: 12115616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
    He B; Qiao X; Cerutti A
    J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.